Hochschulschrift
Acute panmyelosis with myelofibrosis : clinicopathological and molecular features of a rare malignant bone marrow disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
20 cm
- Extent
-
VII, 97 Bl.
- Language
-
Englisch
- Notes
-
Ill., graph. Darst.
Freiburg (Breisgau), Univ., Diss., 2013
- Classification
-
Medizin, Gesundheit
- Creator
-
Kapp-Schwoerer, Silke
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 2:05 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Kapp-Schwoerer, Silke
Other Objects (12)
Myelofibrosis
Vitamin-D Deficiency and Myelofibrosis: A Rare but Reversible Association
Bone Marrow Plasminogen Activator in Malignant Disease
Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosis
Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion
Myelofibrosis Treatment Algorithm 2018
Novel approaches in myelofibrosis
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
Prefibrotic myelofibrosis: treatment algorithm 2018
Digital Papillary Adenocarcinoma, a Rare Malignant Tumor
Myelofibrosis
Vitamin-D Deficiency and Myelofibrosis: A Rare but Reversible Association
Bone Marrow Plasminogen Activator in Malignant Disease
Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosis
Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion
Myelofibrosis Treatment Algorithm 2018
Novel approaches in myelofibrosis
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
Prefibrotic myelofibrosis: treatment algorithm 2018
Digital Papillary Adenocarcinoma, a Rare Malignant Tumor
Myelofibrosis
Vitamin-D Deficiency and Myelofibrosis: A Rare but Reversible Association
Bone Marrow Plasminogen Activator in Malignant Disease
Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosis
Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion
Myelofibrosis Treatment Algorithm 2018
Novel approaches in myelofibrosis
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
Prefibrotic myelofibrosis: treatment algorithm 2018